Emily Mullin
Emily Mullin will on Monday join OneZero, Medium’s technology and science publication, to cover biotechnology.
Mullen was previously a freelance writer who has had bylines in The Washington Post, The Wall Street Journal, Scientific American, National Geographic, The Atlantic, Science, Quartz, Pacific Standard, and The Baltimore Sun, among others.
Her areas of interest include gene therapy, CRISPR, consumer genetics, reproductive technology, brain implants, regenerative medicine, biohacking, and AI in medicine.
She has also worked as associate editor for biomedicine at MIT Technology Review, where she earned a Newsbrief Award from the D.C. Science Writers Association.
She earned her bachelor’s degree in journalism at Ohio University and a master’s in science writing from Johns Hopkins University.
The Indianapolis Business Journal is looking for our next news editor, a role that focuses…
Axios has chosen Ben Berkowitz to be its next managing editor of business and markets.…
Business Insider editor in chief Jamie Heller sent out the following on Monday: I'm thrilled…
Rest of World editor in chief Anup Kaphle sent out the following on Monday: We are excited…
The Financial Times has hired Veena Venugopal as its India newsletter editor. She has been working at…
Benjamin Parkin has been named Middle East and Africa news editor at the Financial Times, based…